Avenir Wellness Solutions (Avenir Wellness Solutions) Cash-to-Debt : 0.02 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Avenir Wellness Solutions Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Avenir Wellness Solutions's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.02.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Avenir Wellness Solutions couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Avenir Wellness Solutions's Cash-to-Debt or its related term are showing as below:

AVRW' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.21 Max: 12.19
Current: 0.02

During the past 8 years, Avenir Wellness Solutions's highest Cash to Debt Ratio was 12.19. The lowest was 0.00. And the median was 0.21.

AVRW's Cash-to-Debt is ranked worse than
95.81% of 1049 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs AVRW: 0.02

Avenir Wellness Solutions Cash-to-Debt Historical Data

The historical data trend for Avenir Wellness Solutions's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Avenir Wellness Solutions Cash-to-Debt Chart

Avenir Wellness Solutions Annual Data

Trend

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

0.08

5.19

0.11

0.29

Avenir Wellness Solutions Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial															0.41	0.29	0.17	0.02	0.02

Competitive Comparison of Avenir Wellness Solutions's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Avenir Wellness Solutions's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avenir Wellness Solutions's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avenir Wellness Solutions's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Avenir Wellness Solutions's Cash-to-Debt falls into.

Avenir Wellness Solutions Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Avenir Wellness Solutions's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.943	/	(10.015	+	0.046)
	=	0.29

Avenir Wellness Solutions's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.189	/	(8.504	+	0)
	=	0.02

Avenir Wellness Solutions (OTCPK:AVRW) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Avenir Wellness Solutions Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Avenir Wellness Solutions's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Avenir Wellness Solutions (Avenir Wellness Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avenir Wellness Solutions Inc (OTCPK:AVRW) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

5805 Sepulveda Boulevard, Suite 801, Sherman Oaks, CA, USA, 91411

Website

https://www.avenirwellness.com

Avenir Wellness Solutions Inc is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on approximately 15 current patents, offers several immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The company sells its product under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips.

Executives

Robert J Costantino	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joel M Bennett	officer: CFO,CAO, Treasurer & Secretary	22619 PACIFIC COAST HIGHWAY, MALIBU CA 90265
Gerald Bagg	director	C/O CURE PHARMACEUTICAL HOLDING CORP., 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Nancy Duitch	officer: Chief Strat Officer-Wellness	15950 ROYAL OAK RD, ENCINO CA 91436
Robert Steven Davidson	director, officer: CEO & Director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Jonathan Berlent	officer: Chief Business Officer	1620 BEACON PLACE, OXNARD CA 93033
John K Bell	director	38 FALLBROOK LANE RR 33, CAMBRIDGE A6 N3H 4R8
Anna Goldin	director	1620 BEACON STREET, OXNARD CA 93033
Lauren Chung	director	1620 BEACON STREET, OXNARD CA 93033
Michael Redard	officer: Chief Financial Officer	1620 BEACON PLACE, OXNARD CA 93033
Joshua Held	director	1620 BEACON PLACE, OXNARD CA 93033
Climate Change Investigation, Innovation & Investment Company, Llc	10 percent owner	12 SAN RAFAEL AVE, BELVEDERE CA 94920
Ruben Jr King-shaw	director	1620 BEACON PLACE, OXNARD CA 93033
Gene Z Salkind	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Alex Katz	officer: CFO	1233 FAIRY HILL ROAD, RYDAL PA 19046